Jeremy Grantham on CNBC’s Closing Bell March 7, 2019
CNBC's Wilfred Frost sits down with Jeremy Grantham to talk about markets and the global economy. To view interview, click here.
2018 Zenith Funds Awards October 5, 2018
GMO Australia was recently named Best Alternative Manager for 2018 by Zenith Fund Awards. For more information please see here.
Barron's June 25, 2018
From a special report on The ABCs of ESG Investing, Jeremy Grantham highlighted among the most influential people in sustainable investing ("How Jeremy Grantham Is Taking on Climate Change" [subscription required for access], by Leslie Norton).
Bond Fund Intelligence December 2018
Editor interviews Tracey Keenan, GMO portfolio manager for Short Duration Strategies ("GMO's Tracey Keenan Talks Short Duration Strategies," by Peter Crane).
Bloomberg December 7, 2018
Bloomberg Opinion columnist Barry Ritholtz interviews Jeremy Grantham for the 'Masters in Business' series ("Jeremy Grantham Discusses Sustainable Investment").
Barron's December 3, 2018
GMO head of Asset Allocation Ben Inker "doesn't see much upside in U.S. stocks over a longer-term horizon because their valuation leaves little room for error" ("Stocks Spring Back to Life, Trade War or Not" [subscription required for access], by Ben Levisohn).
Fortune November 20, 2018
For the magazine's 2019 Investor's Guide, John Thorndike of GMO's Asset Allocation team comments on the outlook for emerging markets ("Why Emerging Markets are a Screaming Buy," by Shawn Tully) and Tom Hancock of the Focused Equity team discusses the approach to the financial sector for the GMO Quality Fund ("The 30 Best Stocks to Buy for 2019 -- in a Bull or Bear Market," by Jen Wieczner and Scott DeCarlo.
Bloomberg November 20, 2018
Neil Constable, head of GMO's Global Equity team, observes low-quality companies with corporate-governance red flags are trading at a premium to the market for the first time since the tech bubble ("The Stocks Rout Is Big, But Not Big Like the Beatles," by John Authers).
ThinkAdvisor November 6, 2018
John Thorndike comments on GMO's asset-class forecasts and relative value in emerging-market equities ("GMO Gives Long-Term View of Best Investments").
The Economist October 27, 2018
Buttonwood columnist quotes James Montier on the challenge of hewing to a value-investment strategy ("The agony of the value investor").
Financial Advisor October 23, 2018
Editor previews Jeremy Grantham's presentation to The SRI Conference dedicated to socially-responsible investing ("Grantham's Optimism on Clean Energy Advances," by Evan Simonoff).
Sunday New York Times October 14, 2018
GMO Climate Change Fund portfolio manager Lucas White comments on companies involved in climate-change mitigation and adaptation ("These Funds Aim to Power Their Returns With Clean Energy," by Tim Gray).
MarketWatch October 11, 2018
Ben Inker comments on risks facing a typical 60/40 stocks/bonds portfolio allocation ("The 'sleep easy' portfolio recommended by your adviser may be riskier than you think," by Brett Arends).
Forbes October 9, 2018
Wallace Forbes interviews Catherine LeGraw, portfolio strategist of GMO's Asset Allocation team ("GMO Forecasts Better Value Outside U.S. Markets").
Advisor Perspectives October 2, 2018
Publication carries Emerging Debt Insights paper by Mustafa Ulukan of GMO's Emerging Country Debt team ("Emerging Corporate Debt Fundamentals -- How High Is the Risk?").
The Wall Street Journal September 25, 2018
Tom Hancock, head of GMO's Focused Equity team, on positioning for a time when the rising tide of economic good news recedes ("Health-Care Stocks Lead This Leg of Rally, After Tech Giants' Stumbles" [subscription required for access], by Michael Wursthorn).
CNBC September 21, 2018
CNBC reports on interview of Catherine LeGraw ("Investor who helps manage $71 billion in global assets says US stocks are too expensive," by Thomas Franck).
TD Ameritrade Network September 17, 2018
Martin Emery, portfolio strategist of GMO's Systematic Global Macro team, interviewed on TD Ameritrade's proprietary video network ("Dr. Martin Emery Discusses the State of the Global Economy").
CNBC PRO September 11, 2018
Senior markets commentator Michael Santoli interviews Catherine LeGraw of GMO's Asset Allocation team ("PRO Talks: Catherine LeGraw" [subscription required for access]).
The Economist August 18, 2018
Buttonwood columnist: GMO's "almost fanatical devotion to value" leads to a heavy weighting of emerging-market shares ("Value judgment: The contrarian case for emerging markets").
ThinkAdvisor August 14, 2018
Ben Inker lays out his arguments for "the most attractive asset" ("GMO's Inker: Stick With Emerging Markets Despite Routs," by Bernice Napach).
Financial Times August 13, 2018
Jeremy Grantham: risks of divestment from oil companies have been vastly overstated ("Environmental risk heats up for pension investors" [subscription required for access], by Chris Flood).
The Wall Street Journal July 26, 2018
Ben Inker: "It is dangerous to assume that returns [on stocks] are going to be 7% from here. People have a strong tendency to extrapolate the unsustainable" ("Saving Too Little? Market Is No Savior" [subscription required for access], by James Mackintosh).
Barron's July 19, 2018
Barron's on GMO's latest asset-class forecasts ("EM, Cash May Be Best Spots for the Next 7 Years, Says GMO" [subscription required for access], by Reshma Kapadia).
The New York Times July 15, 2018
Ben Inker comments on market response to inflation risks ("Long Dormant, Inflation Reawakens Investors' Fears," by Paul Lim).
Morningstar Magazine June 30, 2018
Ben Inker in roundtable discussion with Notre Dame professor of finance Martijn Cremers and Morningstar director of global passive strategies research Ben Johnson ("Morningstar Conversation: Active vs. Passive Redux: How far should managers go?").
Morningstar June 25, 2018
Video of Jeremy Grantham's keynote address to the 2018 Morningstar Investment Conference ("Watch Jeremy Grantham's 'Race of Our Lives' Speech").
Advisor Perspectives June 19, 2018
Publication carries Emerging Debt Insights white paper by Carl Ross of GMO's Emerging Country Debt team ("Emerging Debt in a Rising Interest Rate Environment").
Financial Advisor June 13, 2018
Coverage of Jeremy Grantham's keynote address to the 2018 Morningstar Investment Conference ("Grantham Says Climate Change, Pollution Put Mankind in 'Race for Our Lives'" by Christopher Robbins).
Meb Faber Research May 23, 2018
Host Meb Faber interviews James Montier of GMO's Asset Allocation team ("James Montier, 'There Really Is a Serious Challenge to Try to Put Together an Investment Portfolio That's Going to Generate Half-Decent Returns on a Forward-Looking Basis'").
Reuters May 09, 2018
Hardik Shah, ESG Practice Manager for GMO: emerging-market investors considering ESG factors can not only improve returns, but serve to improve the financial health of those markets ("Why Asian Investors Are Waking Up to ESG Data").
Financial Times May 08, 2018
Arjun Divecha: "Most emerging markets are now also running fairly sound fiscal and economic policies" ("Argentina's stunning rate rises appear to pay off" [subscription required for access], by Joe Rennison, Robin Wigglesworth and Gideon Long).
Pensions & Investments April 30, 2018
Arjun Divecha, head of GMO's Emerging Markets Equity team: "This particular bout of sanctions ... is not going to have a profound impact on [Russia's] overall economic prospects" ("Sanctions slowing investors' interest in Russia" [subscription required for access], by Sophie Baker).
Barron's April 30, 2018
Matt Kadnar of GMO's Asset Allocation team comments in cover story on the outlook for value-focused investment strategies ("Are Value Stocks Ready to Grow Again?" [subscription required for access], by Reshma Kapadia).
Bloomberg April 17, 2018
Bloomberg on GMO's asset-class forecasts ("Grantham Forecasts Rough Seven Years for Equities, Bonds," by Charles Stein).
The Wall Street Journal April 17, 2018
Arjun Divecha: "We've always said you make more money when things go from truly awful to merely bad ... Russia's relationship with the world is now approaching truly awful" ("Russia's Stocks Show Flaw in Chasing 'Value'" [subscription required for access], by James Mackintosh).
New York Times April 15, 2018
Peter Chiappinelli of GMO's Asset Allocation team: "That bonds are a dampener [on portfolio volatility] is not preordained by God" ("Of Investors, and Their Bondage to Bonds," by Carla Fried).
Bloomberg April 13, 2018
Head of GMO's Emerging Country Debt team Tina Vandersteel noted ("Women Are Winning in Bond Funds. Why Aren't There More of Them?," by Liz McCormick).
New York Times April 13, 2018
Binu George, portfolio strategist for GMO's Emerging Markets Equity team, on the "massive opportunity" for investors in emerging markets ("Finding Emerging Markets Stocks With Social Consciences," by Tim Gray).
MarketWatch April 12, 2018
Amit Bhartia of GMO's Emerging Markets Equity team calculates risk of an "earnings crash" for the emerging-market sector ("Should you invest your retirement savings in emerging markets?," by Mark Hulbert).
Financial Times April 11, 2018
Following the announcement of U.S. sanctions on Russia, Arjun Divecha affirms that GMO is "comfortable with our overweight in Russian equities" ("Rough days for Russian debt..." [registration required for access], by Alexandra Scaggs).
The Economist April 10, 2018
Buttonwood columnist revisits Jeremy Grantham on his market outlook ("An update from Jeremy Grantham" [subscription required for access]).
Bloomberg April 05, 2018
For his Masters in Business series, Bloomberg View columnist Barry Ritholtz interviews Matt Kadnar of GMO's Asset Allocation team ("Matthew Kadnar Talks About His Transition From Law to Finance").
Australian Financial Review March 26, 2018
Neil Constable, head of GMO's Global Equity team, on GMO's effort to ensure stock-picking decisions reflect actual economics of underlying businesses ("GMO's Dr Neil Constable on a mission to update corporate books" [subscription required for access]," by Jonathan Shapiro).
Investment Innovation Institute March 21, 2018
Jeremy Grantham: "You've got to learn to take some risk and hit the ball hard. You don't get that many great opportunities to make money." ("The Biggest Risk in Investing is Trying to Avoid It: Grantham," by Wouter Klijn).
Investment News March 15, 2018
Senior columnist interviews Jeremy Grantham ("GMO's Grantham: No bubble yet, but keep your eyes open," by John Waggoner).
The Wall Street Journal March 04, 2018
Ben Inker: "I believe these tariffs on their own will push inflation higher, and higher inflation is a threat to the valuations of more or less all financial assets today" ("Trump's Tough Talk on Trade Rattles Investors [subscription required for access]," by Michael Wursthorn and Amrith Ramkumar).
Australian Financial Review February 28, 2018
Kim Mayer of GMO's Focused Equity team on opportunities in the climate change sector ("Why clean energy players must tread warily [subscription required for access]," by Karen Maley).
Morningstar February 27, 2018
Walking through an argument on high-risk investment strategies from Ben Inker ("The Case for (and Against) Concentrated Funds," by John Rekenthaler).
Business Wire February 26, 2018
GMO Announces Partnership with St. James’s Place; Responds to US Private Wealth Demand (click here to read article).
ThinkAdvisor February 20, 2018
Ben Inker explores whether a portfolio of concentrated, high tracking error, "high conviction" strategies might maximize the probability of meeting or beating a target return ("GMO's Inker: How to Chase Alpha Like Your Life Depends on It," by Janet Levaux).
Financial Times February 13, 2018
James Montier: "Fund managers for the most part all agree that the US market is expensive but still they choose to own equities -- a cynical career-risk-driven position if ever there was one" ("The fully invested bear [subscription required for access]," by Dan McCrum).
Reuters February 05, 2018
Catherine LeGraw: emerging market value stocks "far more attractive than anything else we can find" ("Emerging markets stocks resilient as U.S. sells off," by Rodrigo Campos).
PBS: Consuelo Mack WealthTrack January 26, 2018
Consuelo Mack interviews Jeremy Grantham ("Riding a Market Melt-Up Then Coping With the Melt-Down with Legendary Investor, Jeremy Grantham").
Financial Times January 22, 2018
Arjun Divecha: China's shadow-banking system has grown too quickly ("China Bulls Beat the Shorts for Now [subscription required for access]," by Robin Wigglesworth and Gabriel Wildau).
The New York Times January 14, 2018
Catherine LeGraw notes that investors need not limit themselves to staid industries to gain exposure to attractively priced emerging market stocks ("Bargain Hunters Turn to Emerging Market Stocks," by Paul Lim).
Morningstar January 08, 2018
GMO's real-return expectations for most equity categories are negative, with value-oriented emerging-markets stocks an exception ("Experts Forecast Long-Term Stock and Bond Returns: 2018 Edition," by Christine Benz).
The Wall Street Journal January 08, 2018
GMO favors cheaper emerging-market stocks ("How to Survive a Stock Market Bubble [subscription required for access]," by James Mackintosh).
Financial Times January 05, 2018
Jeremy Grantham on market bubbles ("Global stocks celebrate 2018 with record highs: Renowned strategist warns bull markets show signs of entering 'blow-off' phase [subscription required for access]," by Stephen Smith).
The Economist January 04, 2018
Buttonwood column on Jeremy Grantham's market outlook ("A wild ride in 2018: Is the bubble only starting?" [subscription required for access]).
Barron's January 03, 2018
Jeremy Grantham on price acceleration in gauging market bubbles ("Guess Who's Bubble Spotting Now?" [subscription required for access]).
Economic Times January 01, 2018
Indian daily interviews Arjun Divecha on his view of India and other emerging markets ("Populist measures will be good for the stock market: Arjun Divecha, GMO," by Sanam Mirchandani).